458 related articles for article (PubMed ID: 17547568)
21. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
Win N; Massey E; Lucas G; Sage D; Brown C; Green A; Contreras M; Navarrete C
Hematology; 2007 Oct; 12(5):461-9. PubMed ID: 17852461
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary injury from transfusion-related acute lung injury.
Kopko PM; Popovsky MA
Clin Chest Med; 2004 Mar; 25(1):105-11. PubMed ID: 15062602
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
26. Transfusion related acute lung injury: a pediatric perspective.
Sanchez R; Toy P
Pediatr Blood Cancer; 2005 Sep; 45(3):248-55. PubMed ID: 15852432
[TBL] [Abstract][Full Text] [Related]
27. A touch of TRALI.
Davis A; Mandal R; Johnson M; Makar R; Stowell C; Dzik S
Transfusion; 2008 Mar; 48(3):541-5. PubMed ID: 18067496
[TBL] [Abstract][Full Text] [Related]
28. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
29. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
[TBL] [Abstract][Full Text] [Related]
30. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
31. Recurrent transfusion-related acute lung injury after a two-year interval.
Krochmal JD; Dwyre DM; Swanson KM; Raife TJ; Schlueter AJ
Transfus Med; 2007 Jun; 17(3):192-6. PubMed ID: 17561861
[TBL] [Abstract][Full Text] [Related]
32. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
33. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
34. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
35. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
[TBL] [Abstract][Full Text] [Related]
36. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
Askari S; Nollet K; Debol SM; Brunstein CG; Eastlund T
J Clin Apher; 2002; 17(2):93-6. PubMed ID: 12210713
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related acute lung injury in the paediatric patient: Two case reports and a review of the literature.
Church GD; Price C; Sanchez R; Looney MR
Transfus Med; 2006 Oct; 16(5):343-8. PubMed ID: 16999757
[TBL] [Abstract][Full Text] [Related]
38. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
39. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
40. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
Kopko P; Silva M; Shulman I; Kleinman S
Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
